Planning Strategies’s Ionis Pharmaceuticals IONS Stock Holding History

Planning Strategies’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$634	Buy	+8	New	+$602	﹤0.01%	816

Other funds holding IONS

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Planning Strategies's IONS Position: Q2 2026 in Review

Planning Strategies opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 8 shares worth $634. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings.

477 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Planning Strategies held 8 shares of Ionis Pharmaceuticals worth $634 as of Q2 2026.
Ionis Pharmaceuticals was a new Planning Strategies position in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Planning Strategies's portfolio in Q2 2026, its #816 holding.
477 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.